Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Faulty breast implants-400 Swedish women win compensation

      Faulty breast implants-400 Swedish women win compensation

      Medical Dialogues Bureau30 Nov 2018 9:45 AM IST
      France: A French court on Thursday ordered the German safety certifier that approved defective breast implants for use to compensate around 400...
      Jubilant Life joins hand with Inipharm Inc for over Rs 199 crore

      Jubilant Life joins hand with Inipharm Inc for over Rs 199 crore

      Medical Dialogues Bureau30 Nov 2018 9:30 AM IST
      NEW DELHI: Drug firm Jubilant Life Sciences on Thursday said its subsidiary Drug Discovery and Development Solutions Ltd (DDDSL) Singapore has entered...
      Biocartis associates with AstraZeneca on lung cancer diagnostics

      Biocartis associates with AstraZeneca on lung cancer diagnostics

      Medical Dialogues Bureau30 Nov 2018 9:15 AM IST
      Belgium: Belgian molecular diagnostics company Biocartis Group said on Thursday it had entered into an agreement with British drugmaker AstraZeneca to...
      Bayer to slash 12,000 jobs after Monsanto takeover

      Bayer to slash 12,000 jobs after Monsanto takeover

      Medical Dialogues Bureau30 Nov 2018 9:00 AM IST
      BERLIN: German chemical and pharmaceutical giant Bayer said Thursday it would slash 12,000 jobs in a major restructuring following the mammoth...
      Unilever emerges as leading bidder for GSKs Indian Horlicks business: Sources

      Unilever emerges as leading bidder for GSK's Indian Horlicks business: Sources

      Medical Dialogues Bureau29 Nov 2018 5:27 PM IST
      New Delhi: Unilever has emerged as the leading bidder in a tight contest for GlaxoSmithKline's Indian Horlicks nutrition business, three people...
      Metropolis Healthcare gets SEBI nod, moves for Initial Public Offer

      Metropolis Healthcare gets SEBI nod, moves for Initial Public Offer

      Medical Dialogues Bureau29 Nov 2018 4:32 PM IST
      New Delhi: Metropolis Healthcare has received markets regulator Securities Exchange Board of India's (SEBI) approval to float initial public...
      Zydus Cadila gets USFDA nod for Baclofen, a muscle spasm treatment tablet

      Zydus Cadila gets USFDA nod for Baclofen, a muscle spasm treatment tablet

      Medical Dialogues Bureau29 Nov 2018 4:31 PM IST
      New Delhi: Drug firm Zydus Cadila Tuesday said it has received the final nod from the US health regulator to market generic Baclofen tablets used for...
      OYO appoints Max Healthcares Rohit Kapoor as CEO of new real estate business

      OYO appoints Max Healthcare's Rohit Kapoor as CEO of new real estate business

      Medical Dialogues Bureau29 Nov 2018 4:26 PM IST
      Hospitality firm OYO on Tuesday said it has appointed Max Healthcare Executive Director Rohit Kapoor as the chief executive officer (CEO) of its new...
      Alembic Pharma gets USFDA nod for insomnia treatment drug

      Alembic Pharma gets USFDA nod for insomnia treatment drug

      Medical Dialogues Bureau29 Nov 2018 4:25 PM IST
      Drug firm Alembic Pharmaceuticals has received approval from the US health regulator for Temazepam capsules, used for the treatment of insomnia.The...
      Astellas Pharma gets U.S. nod for blood cancer treatment

      Astellas Pharma gets U.S. nod for blood cancer treatment

      Medical Dialogues Bureau29 Nov 2018 9:18 AM IST
      By Tamara Mathias and Manas MishraThe U.S. Food and Drug Administration on Wednesday approved a blood cancer treatment from Japan's Astellas Pharma...
      Atrium Health says data of about 2.65 mln patients involved in breach

      Atrium Health says data of about 2.65 mln patients involved in breach

      Medical Dialogues Bureau29 Nov 2018 9:17 AM IST
      Atrium Health, previously Carolinas HealthCare System, said on Tuesday data of about 2.65 million patients including addresses, dates of birth and...
      Chinese medical tech platform WuXi AppTec launches $1 Billion HK listing

      Chinese medical tech platform WuXi AppTec launches $1 Billion HK listing

      Medical Dialogues Bureau29 Nov 2018 9:17 AM IST
      HONG KONG: Shanghai-listed Chinese medical tech platform WuXi AppTec has launched a Hong Kong listing of up to $1.06 billion, braving weak markets and...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok